Friedrich Jung | Radiology | Best Researcher Award

Prof. Dr. Friedrich Jung | Radiology | Best Researcher Award

Brandenburg Technical University | Germany

Professor Dr. Friedrich Jung is a distinguished biomedical scientist renowned for his pioneering contributions to molecular cell biology, biomaterials, and clinical hemorheology. He has built an illustrious career across leading German research institutions, serving in key academic and leadership roles, including as Director of the Institute for Heart and Circulation Research in Dresden and Head of the Department of Biointerface Engineering at the Berlin Brandenburg Center for Regenerative Therapies. With a strong academic foundation in physical and biomedical engineering from RWTH Aachen and Saarland University, he has significantly advanced the understanding of cell–material interactions and blood–biomaterial compatibility. His research interests encompass biomaterial development, molecular mechanisms of vascular responses, regenerative medicine, and translational biotechnologies aimed at improving clinical outcomes. Highly skilled in experimental cell biology, biointerface engineering, and quality management in biomedical systems, he has authored hundreds of peer-reviewed publications, book chapters, and scientific volumes. Professor Jung’s achievements have been recognised with prestigious honours such as the Robin Fahraeus, Otfried-Müller, and Oskar Orth Awards, and he has held leadership positions in European scientific societies. A visionary scholar and mentor, he continues to inspire innovation in biomedical science, bridging engineering and medicine for the advancement of human health and regenerative therapies.

Profile: Scopus

Featured Publications

Siman Cai | Ultrasound | Young Scientist Award

Dr. Siman Cai | Ultrasound | Young Scientist Award

Peking Union Medical College Hospital | China

Dr. Siman Cai is a medical ultrasound specialist conducting advanced research in hemodynamic imaging and tumor diagnostics. She has focused on applying multiple innovative ultrasound technologies, including superb microvascular imaging and shear-wave elastography, to evaluate tumor vascular architecture and improve diagnostic accuracy. Her work has contributed to understanding the vascular patterns of gliomas, their differentiation grades, and molecular subtypes, as well as breast lesions, providing valuable quantitative indicators for distinguishing benign and malignant tumors. Dr. Cai has demonstrated the clinical relevance of these imaging modalities in both preoperative and intraoperative settings, enhancing tumor boundary identification and aiding in total tumor resection. Her publications highlight the diagnostic value of vascular indices and imaging-derived markers for precision oncology. Through her work, she has bridged technological innovation with clinical applications, advancing the accuracy of tumor diagnosis and the effectiveness of treatment planning in neuro-oncology and breast cancer imaging.

Profile

ORCID

Education

Dr. Siman Cai received her professional doctorate in medical ultrasound from the Chinese Academy of Medical Sciences & Peking Union Medical College, where she specialized in diagnostic imaging and clinical applications of ultrasound technologies. Her education emphasized understanding tumor biology and vascular physiology, equipping her with the skills to combine imaging innovation with clinical diagnostics. During her academic training, she focused on superb microvascular imaging, multiparametric ultrasound, and elastography to investigate the structural and functional characteristics of tumors. She gained experience in designing and implementing studies that integrate quantitative vascular indices with histopathological and molecular analyses. Her education provided a foundation for translational research, linking imaging findings to surgical and therapeutic outcomes. With rigorous training in both clinical ultrasound techniques and research methodology, Dr. Cai is well-prepared to advance precision diagnostics in oncology, particularly in the evaluation of gliomas and breast lesions, using state-of-the-art ultrasound modalities to enhance patient care.

Experience

Dr. Siman Cai is currently a resident doctor in medical ultrasound at Peking Union Medical College Hospital in Beijing, where she applies advanced ultrasound techniques in clinical practice. She has gained extensive experience performing intraoperative and diagnostic imaging for patients with brain tumors and breast lesions. Her work includes evaluating vascular architecture using superb microvascular imaging and shear-wave elastography to guide surgical decisions and improve diagnostic precision. Dr. Cai collaborates with multidisciplinary teams to integrate imaging findings into clinical workflows, contributing to accurate tumor grading, identification of molecular subtypes, and total tumor resection. She has also participated in clinical studies assessing quantitative vascular indices as predictive markers for tumor malignancy. Her professional experience bridges research and patient care, allowing her to implement novel imaging approaches in routine clinical practice and contribute to improving diagnostic efficiency and treatment outcomes. Her combined clinical and research expertise positions her as an emerging leader in ultrasound-based tumor diagnostics.

Awards and Honors

Dr. Siman Cai has been recognized for her innovative contributions to medical imaging and tumor diagnostics. Her work in superb microvascular imaging and shear-wave elastography has received attention in the oncology community for improving diagnostic accuracy in brain and breast tumors. She has contributed to multiple high-impact publications in respected journals, highlighting the clinical relevance of her research. Her achievements include advancing preoperative and intraoperative imaging approaches to support total tumor resection and precise tumor grading. Dr. Cai’s research has demonstrated the potential of ultrasound-based vascular indices as quantitative biomarkers for differentiating tumor malignancy and molecular subtypes. She is acknowledged for integrating cutting-edge imaging technologies into clinical practice, enhancing both research and patient care. Through her publications, clinical contributions, and innovative research methodologies, she has established herself as a promising expert in the field of ultrasound diagnostics and precision oncology, earning professional recognition among peers and mentors.

Research Focus

Dr. Siman Cai’s research focuses on applying advanced ultrasound imaging technologies to improve tumor diagnosis and treatment planning. She investigates the vascular architecture of gliomas and breast lesions using superb microvascular imaging, shear-wave elastography, and multiparametric ultrasound. Her work examines quantitative vascular indices, structural patterns, and microvascular features as diagnostic markers for differentiating benign and malignant tumors, identifying tumor boundaries, grading gliomas, and determining molecular subtypes. She explores intraoperative imaging techniques to assist total tumor resection and optimize surgical outcomes. Her research also evaluates the clinical value of integrating ultrasound-derived vascular indices with histopathology and molecular profiling. By bridging imaging innovation with clinical applications, Dr. Cai aims to enhance precision diagnostics and individualized treatment strategies. Her studies contribute to understanding tumor hemodynamics, improving diagnostic confidence, and providing non-invasive tools for monitoring tumor progression. Her ultimate goal is to advance ultrasound-based imaging as a reliable, accurate, and clinically actionable method in oncology.

 

Publications

 

Title: Role of Multiparametric Ultrasound in Predicting the IDH Mutation in Gliomas: Insights from Intraoperative B-Mode, SWE, and SMI Modalities
Year: 2025

Title: Clinical application of intraoperative ultrasound superb microvascular imaging in brain tumors resections: contributing to the achievement of total tumoral resection
Year: 2024

Title: Intraoperative shear-wave elastography and superb microvascular imaging contribute to the glioma grading
Year: 2023

Title: Association Between Vascular Index Measured via Superb Microvascular Imaging and Molecular Subtype of Breast Cancer
Year: 2022

Title: Relationship Between Serum Lipid Profiles and Carotid Intraplaque Neovascularization in a High–Stroke‐Risk Population: A Cross‐Sectional Study in China
Year: 2021

Conclusion

Dr. Siman Cai is an emerging expert in medical ultrasound, dedicated to advancing tumor diagnostics through innovative imaging technologies, translating research findings into clinical practice, and improving surgical precision and patient outcomes in neuro-oncology and breast cancer.

Nuo Yu | Radiomics | Best Researcher Award

Ms. Nuo Yu | Radiomics | Best Researcher Award

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ,China

Nuo Yu is a Ph.D. candidate at the Cancer Institute and Hospital of the Chinese Academy of Medical Sciences, specializing in radiation oncology with a focus on esophageal squamous cell carcinoma (ESCC). His research primarily explores innovative chemoradiotherapy regimens to improve treatment outcomes for patients with locally advanced ESCC.

Yu has contributed to several peer-reviewed publications in SCI-indexed journals. Notably, he co-authored a study titled “Conversion Chemoradiotherapy Combined with Nab-Paclitaxel Plus Cisplatin in Patients with Locally Advanced Borderline-Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase I/II Prospective Cohort Study,” published in Strahlentherapie und Onkologie in August 2024. This research evaluated the efficacy and safety of a novel chemoradiotherapy regimen, demonstrating promising results in locoregional control and overall survival rates.

In March 2023, Yu co-authored another significant study, “Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic Study,” published in Current Cancer Drug Targets. This research focused on treatment strategies for elderly patients with ESCC, highlighting the potential benefits of combining chemoradiotherapy with nimotuzumab.

Yu’s work has been recognized at international conferences, including presentations at the American Society for Radiation Oncology (ASTRO), the Federation of Asian Organizations for Radiation Oncology (FARO), and the Korean Society for Radiation Oncology (KOSRO). These engagements underscore his active participation in the global radiation oncology community and his commitment to advancing cancer treatment research.

While still in the early stages of his career, Yu’s focused research on ESCC and his contributions to the field of radiation oncology position him as a promising candidate for the Best Researcher Award. Continued efforts to expand his research scope, increase publication impact, and assume leadership roles in larger-scale studies will further strengthen his candidacy.

Profile

Scientific Publications